drugset / Trial / NCT02129647
Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if the study drug, AXITINIB, has any effect on tumors found in patients with Neurofibromatosis Type 2 (NF2).
Timeline
- Start
- 2014-04
- Primary completion
- 2019-02-05
- Completion
- 2019-02-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axitinib | Small molecule | 10 mg | Oral |